Prevention of radiocontrast nephropathy: Back to basics

JAMA

Volumn 291, Issue 19, 2004, Pages 2376-2377

  Chertow, Glenn M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ADENOSINE RECEPTOR BLOCKING AGENT; ANTIOXIDANT; BICARBONATE; CONTRAST MEDIUM; DOPAMINE; INFUSION FLUID; LOOP DIURETIC AGENT; OSMOTIC DIURETIC AGENT; SODIUM CHLORIDE; VASODILATOR AGENT; ORAL REHYDRATION SOLUTION;

ACUTE KIDNEY FAILURE; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; DRUG COST; DRUG MECHANISM; DRUG SAFETY; EDITORIAL; HEMODIALYSIS; HEMOFILTRATION; HUMAN; KIDNEY DISEASE; METABOLIC ACIDOSIS; NEPHROTOXICITY; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; NOTE; RADIOGRAPHY;

CONTRAST MEDIA; HUMANS; KIDNEY FAILURE, ACUTE; RADIOGRAPHY; REHYDRATION SOLUTIONS; SODIUM BICARBONATE;

EID: 2442542222     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.291.19.2376     Document Type: Editorial

References (17)

1. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA. 2004; 291:2328-2334.
2. Levy EM, Viscoli CM, Hurwitz RI. The effect of acute renal failure on mortality: a cohort analysis. JAMA. 1996;275:1489-1494.
3. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention. Am J Med. 1997;103:368-375.
4. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177-182.
5. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide on acute changes in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416-1420.
6. Gare M, Haviv YS, Ben-Yehuda A, et al. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol. 1999;34:1682-1688.
7. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy. JAMA. 2003;290:2284-2291.
8. Erley CM, Duda SH, Schlepckow S, et al. Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. Kidney Int. 1994;45:1425-1431.
9. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-184.
10. Durham JD, Caputo C, Dokko J, et al. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int. 2002;62:2202-2207.
11. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention. JAMA. 2003;289:553-558.
12. Marenzi G, Marana I, Lauri G, et al. The prevention of radiocontrast-agent-induced nephropathy by hemofiltration. N Engl J Med. 2003;349:1333-1340.
13. Kshirsagar AV, Poole C, Mottl A, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy. J Am Soc Nephrol. 2004;15:761-769.
14. Pannu N, Manns B, Lee H, Tonelli M. Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney Int. 2004;65:1366-1374.
15. Hoffmann U, Fischereder M, Kruger B, et al. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol. 2004;15:407-410.
16. Bates DW, Su L, Yu DT, et al. The mortality and costs of acute renal failure associated with amphotericin B therapy. Clin Infect Dis. 2001;32:686-693.
17. Scheingraber S, Rehm M, Sehmisch C, et al. Rapid saline infusion produces hyperchloremic acidosis in patients undergoing gynecologic surgery. Anesthesiology. 1999;90:1265-1270.